These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 10455520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL, Khosla S, Melton LJ.
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [Abstract] [Full Text] [Related]

  • 3. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
    Gallagher JC, Fowler SE, Detter JR, Sherman SS.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calcium and osteoporosis.
    Nordin BE.
    Nutrition; 1997 Aug; 13(7-8):664-86. PubMed ID: 9263260
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D, Giljevic Z, Kraljevic I, Korsic M.
    Med Hypotheses; 2006 Aug; 67(5):1052-3. PubMed ID: 16790322
    [Abstract] [Full Text] [Related]

  • 10. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study.
    Khosla S, Atkinson EJ, Melton LJ, Riggs BL.
    J Clin Endocrinol Metab; 1997 May; 82(5):1522-7. PubMed ID: 9141544
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C.
    Int J Fertil Menopausal Stud; 1993 May; 38 Suppl 1():45-54. PubMed ID: 8499959
    [Abstract] [Full Text] [Related]

  • 13. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M, Levancini M.
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Background for studies on the treatment of male osteoporosis: state of the art.
    Kaufman JM, Johnell O, Abadie E, Adami S, Audran M, Avouac B, Sedrine WB, Calvo G, Devogelaer JP, Fuchs V, Kreutz G, Nilsson P, Pols H, Ringe J, Van Haelst L, Reginster JY.
    Ann Rheum Dis; 2000 Oct; 59(10):765-72. PubMed ID: 11005775
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis and management of primary osteoporosis.
    Bauwens SF, Drinka PJ, Boh LE.
    Clin Pharm; 1986 Aug; 5(8):639-59. PubMed ID: 3527528
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men.
    Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES.
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3908-15. PubMed ID: 16849417
    [Abstract] [Full Text] [Related]

  • 20. [Sex hormone replacement following menopause--for all women? A plea for prevention using estrogens and gestagens].
    Nocke W.
    Ther Umsch; 1995 Oct; 52(10):693-704. PubMed ID: 7482382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.